Home › Idiopathic Pulmonary Fibrosis › Arizona
Idiopathic Pulmonary Fibrosis clinical trials in Arizona
5 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Arizona.
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Phoenix
- Research Site, Phoenix
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 21, 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Arizona, Tucson
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT07002034Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Arizona, Tucson
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer site in Phoenix, AZ, Phoenix
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 10, 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- HonorHealth Research Institute, Scottsdale
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Nov 12, 2025 · NCT05975983From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.